UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012066
Receipt number R000014106
Scientific Title The observational study of the safety assesment during the periendoscopic period in antithrombotic drug-users
Date of disclosure of the study information 2013/10/18
Last modified on 2020/11/12 08:38:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The observational study of the safety assesment during the periendoscopic period in antithrombotic drug-users

Acronym

O-GUTS clinical study of antithrombotic drugs

Scientific Title

The observational study of the safety assesment during the periendoscopic period in antithrombotic drug-users

Scientific Title:Acronym

O-GUTS clinical study of antithrombotic drugs

Region

Japan


Condition

Condition

The case of endoscopic forceps biopsy or endoscopic treatment in patients taking antithrombotic drugs

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety of the guideline for endoscopic procedures in antithrombotic drug-users from Japan Gastroenterological Endoscopy Society on July 2012

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of bleeding after endoscopic forceps biopsy or endoscopic treatment

Key secondary outcomes

1)The incidence of thromboembolic events
2)The incidence of complications except for bleeding


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients who were given a written informed consent
2)Patients who take antithrombotic drugs and need endoscopic forceps biopsy or endoscopic treatment

Key exclusion criteria

Patients who were disqualified for the study by their physiciens

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Okada

Organization

Okayama University Hospital

Division name

Department of Endoscopy

Zip code


Address

2-5-1, 2-5-1 Shikata-cho, Kita-ku, Okayama 700 8558, Japan

TEL

086-235-7219

Email

hiro@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiyasu Kono, Minoru Matsubara

Organization

Okayama University Hospital

Division name

Department of Gastroenterology

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama 700 8558, Japan

TEL

086-235-7219

Homepage URL


Email

hxnwq178@yahoo.co.jp


Sponsor or person

Institute

Department of Gastroenterology, Okayama University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 25 Day

Date of IRB

2013 Year 07 Month 23 Day

Anticipated trial start date

2013 Year 10 Month 17 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observance rate of the guideline


Management information

Registered date

2013 Year 10 Month 18 Day

Last modified on

2020 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014106


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name